Company Filing History:
Years Active: 1997
Title: Jurgen Punter: Innovator in Immunological Determination
Introduction
Jurgen Punter, an accomplished inventor based in Hofheim am Taunus, Germany, has made significant contributions to the field of immunology. With a patent under his name, Punter has shown his innovative prowess in the development of monoclonal antibodies, enhancing the accuracy of immunological determinations.
Latest Patents
Punter holds a notable patent concerning monoclonal antibodies designed for the selective immunological determination of procollagen peptides. This innovative patent emphasizes the use of a monoclonal antibody that targets a specific epitope of amino-terminal procollagen peptide (type III) which is absent in the collagen fragment Col 1. Notably, this technology demonstrates immense potential, allowing for precise determinations of the procollagen peptide in body fluids, thus advancing the diagnostics in related medical fields.
Career Highlights
Jurgen Punter has made a mark in the scientific community through his role at Hoechst Aktiengesellschaft, where he has contributed to groundbreaking research and development in immunological applications. His work has had a significant impact, opening new avenues for diagnostics and therapeutic interventions.
Collaborations
Throughout his career, Punter has collaborated with esteemed colleagues such as Dietrich Brocks and Helmut Strecker, who have both since passed away. These collaborations indicate a rich legacy of teamwork and shared innovation in the field of immunology.
Conclusion
In summary, Jurgen Punter stands out as a notable figure in the realm of immunological research with his groundbreaking patent on monoclonal antibodies. His contributions, both individually and through collaboration, continue to influence advancements in medical diagnostics. His innovative spirit exemplifies the essence of invention, paving the way for future breakthroughs in medical science.